EICHOR
● Active Not Recruiting
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
Condition: HIV-1-infection · Sponsor: Gilead Sciences
About this study
The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC)/lenacapavir (LEN), fixed-dose combination (FDC) versus current therapy bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) FDC in people living with HIV-1 (PWH). The primary objective of this study is to learn how effective it is to switch to BIC/LEN FDC tablets versus continuing on B/F/TAF FDC tablets in virologically suppressed PWH.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (104)
| Pueblo Family Physicians | Phoenix, Arizona, United States | — |
| Be Well Medical Center | Berkeley, California, United States | — |
| Pacific Oaks Medical Group | Beverly Hills, California, United States | — |
| Ruane Clinical Research Group Inc. | Los Angeles, California, United States | — |
| Alta Bates Summit Medical Center, Summit Campus, East Bay Advanced Care | Oakland, California, United States | — |
| BIOS Clinical Research | Palm Springs, California, United States | — |
| UCSD Anti Viral Research Centre (AVRC) | San Diego, California, United States | — |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Torrance, California, United States | — |
| Mills Clinical Research | West Hollywood, California, United States | — |
| Public Health Institute at Denver Health | Denver, Colorado, United States | — |
| Yale University School of Medicine (study visits) | New Haven, Connecticut, United States | — |
| Midland Florida Infectious Diseases Specialists, PL - Orange City | DeLand, Florida, United States | — |
+ 92 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06333808